CLINICAL_TRIALS
trial_result
· 2022-12-12
Clinical Trial Update: Parallel Arm Trial of AD109 and AD504 In Patients With OSA [Phase 2]
Summary
Phase 2 parallel-arm trial of AD109 and AD504 in obstructive sleep apnea has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Apnimed | Conditions: OSA - Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED